Titan Pharmaceuticals

TTNP · NASDAQ

$4.61−$0.18 (−3.76%)TodayMarket closed · Oct 1, 3:19 PM ET

No price history for this range.

About TTNP

Titan Pharmaceuticals Inc is a US-based company operating in IT Services industry. The company is headquartered in New York City, New York. Titan Pharmaceuticals, Inc. is a pharmaceutical company. Its product pipeline includes Kappa Opioid Receptor Agonist (TP-2021) Implant, which is used for the treatment of moderate-to-severe chronic pruritus, and Nalmefene Implant, which is for the prevention of relapse in OUD patients following detoxification from opioids Its product development programs are in non-clinical stages of development.

Employees: 4
Headquarters: New York City, New York
Listed: Jan 18, 1996
Sector: Information Technology
Industry: IT Services
Website: titanpharm.com

Revenue by product and region

Fiscal year ended Dec 31, 2021: $1.53M total revenue

By product

Grant revenue$1.28M83.7%
Product revenue$236.00K15.5%
License revenue$13.00K0.9%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Titan Pharmaceuticals suppliers and customers
Company	Relationship	Country	Correlation
Viatris VTRS	Supplier and customer	US	0.61
Knight Therapeutics GUD.TO	Supplier and customer	CA	-0.24
United States	Supplier and customer	US	—
ILSL Holdings, Inc.	Supplier and customer	US	—
Southwest Research Institute	Supplier and customer	US	—

Similar companies

Companies in the same industry as Titan Pharmaceuticals

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.